Tapewire

Nasdaq · USD

ACRS

Aclaris Therapeutics, Inc.

Export transactions ↓
Tapewire entity
5041
SEC CIK
0001557746
Parsed reports
365

Last 12 months

Inside the activity.

0 purchase rows · 1 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202601
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 05, 2021 Filed May 6, 2021 00:04 UTC
Ali-Jackson KamilChief Legal Officer
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $10.66 $0.00
Disclosure

SEC source: 0001209191-21-030491 · doc4.xml · derivative · entry 12

Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,416

Underlying: Common Stock · 35,416 shares

Expires 2025-08-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: The option is fully vested.

Read SEC document
May 05, 2021 Filed May 6, 2021 00:04 UTC
Ali-Jackson KamilChief Legal Officer
SaleCommon Stock 498 $24.36 $12,129.24
Disclosure

SEC source: 0001209191-21-030491 · doc4.xml · nonDerivative · entry 9

Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 143,618

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2021.

F7 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $24.33 to $24.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 05, 2021 Filed May 6, 2021 00:04 UTC
Ali-Jackson KamilChief Legal Officer
SaleCommon Stock 14,502 $23.97 $347,583.94
Disclosure

SEC source: 0001209191-21-030491 · doc4.xml · nonDerivative · entry 8

Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 144,116

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2021.

F6 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $23.32 to $24.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 05, 2021 Filed May 6, 2021 00:04 UTC
Ali-Jackson KamilChief Legal Officer
Exercise / conversionCommon Stock 15,000 $10.66 $159,900.00
Disclosure

SEC source: 0001209191-21-030491 · doc4.xml · nonDerivative · entry 7

Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 158,618

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 04, 2021 Filed May 6, 2021 00:04 UTC
Ali-Jackson KamilChief Legal Officer
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $10.66 $0.00
Disclosure

SEC source: 0001209191-21-030491 · doc4.xml · derivative · entry 11

Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,416

Underlying: Common Stock · 50,416 shares

Expires 2025-08-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: The option is fully vested.

Read SEC document
May 04, 2021 Filed May 6, 2021 00:04 UTC
Ali-Jackson KamilChief Legal Officer
SaleCommon Stock 1,279 $24.47 $31,295.98
Disclosure

SEC source: 0001209191-21-030491 · doc4.xml · nonDerivative · entry 6

Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 143,618

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2021.

F5 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $24.19 to $24.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 04, 2021 Filed May 6, 2021 00:04 UTC
Ali-Jackson KamilChief Legal Officer
SaleCommon Stock 13,721 $23.61 $323,891.07
Disclosure

SEC source: 0001209191-21-030491 · doc4.xml · nonDerivative · entry 5

Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 144,897

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2021.

F4 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $23.17 to $24.13, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 04, 2021 Filed May 6, 2021 00:04 UTC
Ali-Jackson KamilChief Legal Officer
Exercise / conversionCommon Stock 15,000 $10.66 $159,900.00
Disclosure

SEC source: 0001209191-21-030491 · doc4.xml · nonDerivative · entry 4

Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 158,618

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 03, 2021 Filed May 6, 2021 00:04 UTC
Ali-Jackson KamilChief Legal Officer
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $10.66 $0.00
Disclosure

SEC source: 0001209191-21-030491 · doc4.xml · derivative · entry 10

Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,416

Underlying: Common Stock · 65,416 shares

Expires 2025-08-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: The option is fully vested.

Read SEC document
May 03, 2021 Filed May 6, 2021 00:04 UTC
Ali-Jackson KamilChief Legal Officer
SaleCommon Stock 4,339 $24.91 $108,073.64
Disclosure

SEC source: 0001209191-21-030491 · doc4.xml · nonDerivative · entry 3

Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 143,618

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2021.

F3 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $24.82 to $24.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 03, 2021 Filed May 6, 2021 00:04 UTC
Ali-Jackson KamilChief Legal Officer
SaleCommon Stock 10,661 $24.46 $260,744.61
Disclosure

SEC source: 0001209191-21-030491 · doc4.xml · nonDerivative · entry 2

Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 147,957

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2021.

F2 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $23.82 to $24.81, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 03, 2021 Filed May 6, 2021 00:04 UTC
Ali-Jackson KamilChief Legal Officer
Exercise / conversionCommon Stock 15,000 $10.66 $159,900.00
Disclosure

SEC source: 0001209191-21-030491 · doc4.xml · nonDerivative · entry 1

Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 158,618

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 26, 2021 Filed Apr 27, 2021 01:45 UTC
Ruffo FrankChief Financial Officer
SaleCommon Stock 100 $26.44 $2,644.00
Disclosure

SEC source: 0001209191-21-028453 · doc4.xml · nonDerivative · entry 5

Ruffo Frank · CIK 0001654450 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 151,720

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2021.

Read SEC document
April 26, 2021 Filed Apr 27, 2021 01:45 UTC
Ruffo FrankChief Financial Officer
SaleCommon Stock 27,239 $25.79 $702,583.70
Disclosure

SEC source: 0001209191-21-028453 · doc4.xml · nonDerivative · entry 4

Ruffo Frank · CIK 0001654450 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 151,820

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2021.

F5 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $25.38 to $26.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 23, 2021 Filed Apr 27, 2021 01:45 UTC
Ruffo FrankChief Financial Officer
SaleCommon Stock 800 $27.33 $21,862.96
Disclosure

SEC source: 0001209191-21-028453 · doc4.xml · nonDerivative · entry 3

Ruffo Frank · CIK 0001654450 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 179,059

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2021.

F4 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $27.23 to $27.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 23, 2021 Filed Apr 27, 2021 01:45 UTC
Ruffo FrankChief Financial Officer
SaleCommon Stock 29,200 $26.64 $777,797.48
Disclosure

SEC source: 0001209191-21-028453 · doc4.xml · nonDerivative · entry 2

Ruffo Frank · CIK 0001654450 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 179,859

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2021.

F3 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $26.23 to $27.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 22, 2021 Filed Apr 27, 2021 01:43 UTC
Walker NealDirector · President and CEO
SaleCommon Stock 30,000 $26.84 $805,239.00
Disclosure

SEC source: 0001209191-21-028451 · doc4.xml · nonDerivative · entry 1

Walker Neal · CIK 0001604457 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,192,427

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021.

F2 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $26.51 to $27.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 22, 2021 Filed Apr 27, 2021 01:45 UTC
Ruffo FrankChief Financial Officer
SaleCommon Stock 30,000 $26.84 $805,218.00
Disclosure

SEC source: 0001209191-21-028453 · doc4.xml · nonDerivative · entry 1

Ruffo Frank · CIK 0001654450 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 209,059

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2021.

F2 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $26.51 to $27.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 11, 2021 Filed Nov 22, 2021 21:03 UTC
Ali-Jackson KamilChief Legal Officer
GiftCommon Stock 7,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-066084 · doc4.xml · nonDerivative · entry 1

Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,696

Read SEC document
March 02, 2021 Filed Mar 4, 2021 01:39 UTC
Ali-Jackson KamilChief Legal Officer
Exercise / conversionRestricted stock units · Derivative 6,637 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-017544 · doc4.xml · derivative · entry 8

Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,914

Underlying: Common Stock · 6,637 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

F6 · derivative.exercise_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 2, 2021, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.

F6 · derivative.expiration_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 2, 2021, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.

Read SEC document
March 02, 2021 Filed Mar 4, 2021 01:39 UTC
Ali-Jackson KamilChief Legal Officer
Tax withholdingCommon Stock 1,906 $23.25 $44,314.50
Disclosure

SEC source: 0001209191-21-017544 · doc4.xml · nonDerivative · entry 4

Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 143,618

F2 · kind: The transaction reported represents the withholding of shares by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of the restricted stock units being reported in this Form 4.

Read SEC document
March 02, 2021 Filed Mar 4, 2021 01:39 UTC
Ali-Jackson KamilChief Legal Officer
Exercise / conversionCommon Stock 6,637 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-017544 · doc4.xml · nonDerivative · entry 3

Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 145,524

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

Read SEC document
March 02, 2021 Filed Mar 4, 2021 01:42 UTC
Gordon David N.Chief Medical Officer
Exercise / conversionRestricted stock units · Derivative 8,297 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-017555 · doc4.xml · derivative · entry 8

Gordon David N. · CIK 0001751167 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,892

Underlying: Common Stock · 8,297 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

F6 · derivative.exercise_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 2, 2021, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.

F6 · derivative.expiration_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 2, 2021, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.

Read SEC document
March 02, 2021 Filed Mar 4, 2021 01:42 UTC
Gordon David N.Chief Medical Officer
Tax withholdingCommon Stock 2,280 $23.25 $53,010.00
Disclosure

SEC source: 0001209191-21-017555 · doc4.xml · nonDerivative · entry 4

Gordon David N. · CIK 0001751167 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,492

F2 · kind: The transaction reported represents the withholding of shares by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of the restricted stock units being reported in this Form 4.

Read SEC document
March 02, 2021 Filed Mar 4, 2021 01:42 UTC
Gordon David N.Chief Medical Officer
Exercise / conversionCommon Stock 8,297 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-017555 · doc4.xml · nonDerivative · entry 3

Gordon David N. · CIK 0001751167 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,772

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

Read SEC document
March 02, 2021 Filed Mar 4, 2021 01:36 UTC
Ruffo FrankChief Financial Officer
Exercise / conversionRestricted stock units · Derivative 8,297 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-017533 · doc4.xml · derivative · entry 8

Ruffo Frank · CIK 0001654450 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,892

Underlying: Common Stock · 8,297 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

F6 · derivative.exercise_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 2, 2021, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.

F6 · derivative.expiration_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 2, 2021, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.

Read SEC document
March 02, 2021 Filed Mar 4, 2021 01:36 UTC
Ruffo FrankChief Financial Officer
Tax withholdingCommon Stock 2,844 $23.25 $66,123.00
Disclosure

SEC source: 0001209191-21-017533 · doc4.xml · nonDerivative · entry 4

Ruffo Frank · CIK 0001654450 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 239,059

F2 · kind: The transaction reported represents the withholding of shares by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of the restricted stock units being reported in this Form 4.

Read SEC document
March 02, 2021 Filed Mar 4, 2021 01:36 UTC
Ruffo FrankChief Financial Officer
Exercise / conversionCommon Stock 8,297 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-017533 · doc4.xml · nonDerivative · entry 3

Ruffo Frank · CIK 0001654450 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 241,903

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

Read SEC document
March 02, 2021 Filed Mar 4, 2021 01:32 UTC
Walker NealDirector · President and CEO
Exercise / conversionRestricted stock units · Derivative 18,253 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-017519 · doc4.xml · derivative · entry 8

Walker Neal · CIK 0001604457 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,762

Underlying: Common Stock · 18,253 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

F6 · derivative.exercise_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 2, 2021, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.

F6 · derivative.expiration_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 2, 2021, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.

Read SEC document
March 02, 2021 Filed Mar 4, 2021 01:32 UTC
Walker NealDirector · President and CEO
Tax withholdingCommon Stock 7,982 $23.25 $185,581.50
Disclosure

SEC source: 0001209191-21-017519 · doc4.xml · nonDerivative · entry 4

Walker Neal · CIK 0001604457 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,222,427

F2 · kind: The transaction reported represents the withholding of shares by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of the restricted stock units being reported in this Form 4.

Read SEC document
March 02, 2021 Filed Mar 4, 2021 01:32 UTC
Walker NealDirector · President and CEO
Exercise / conversionCommon Stock 18,253 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-017519 · doc4.xml · nonDerivative · entry 3

Walker Neal · CIK 0001604457 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,230,409

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

Read SEC document
March 01, 2021 Filed Mar 4, 2021 01:39 UTC
Ali-Jackson KamilChief Legal Officer
Exercise / conversionRestricted stock units · Derivative 17,175 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-017544 · doc4.xml · derivative · entry 7

Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,350

Underlying: Common Stock · 17,175 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

F5 · derivative.exercise_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2020, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.

F5 · derivative.expiration_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2020, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.

Read SEC document
March 01, 2021 Filed Mar 4, 2021 01:39 UTC
Ali-Jackson KamilChief Legal Officer
GrantRestricted stock units · Derivative 28,400 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-017544 · doc4.xml · derivative · entry 6

Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,400

Underlying: Common Stock · 28,400 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

F4 · derivative.exercise_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2022, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.

F4 · derivative.expiration_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2022, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.

Read SEC document
March 01, 2021 Filed Mar 4, 2021 01:39 UTC
Ali-Jackson KamilChief Legal Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 99,500 $0.00 Strike: $24.06 $0.00
Disclosure

SEC source: 0001209191-21-017544 · doc4.xml · derivative · entry 5

Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,500

Underlying: Common Stock · 99,500 shares

Expires 2031-02-28

F3 · derivative.exercise_date: Exercisable with respect to 25% of the shares subject to the option vesting on each of the first, second, third and fourth anniversaries of the grant date, subject to Reporting Person's continuous service through each such date.

Read SEC document
March 01, 2021 Filed Mar 4, 2021 01:39 UTC
Ali-Jackson KamilChief Legal Officer
Tax withholdingCommon Stock 4,934 $24.06 $118,712.04
Disclosure

SEC source: 0001209191-21-017544 · doc4.xml · nonDerivative · entry 2

Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 138,887

F2 · kind: The transaction reported represents the withholding of shares by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of the restricted stock units being reported in this Form 4.

Read SEC document
March 01, 2021 Filed Mar 4, 2021 01:39 UTC
Ali-Jackson KamilChief Legal Officer
Exercise / conversionCommon Stock 17,175 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-017544 · doc4.xml · nonDerivative · entry 1

Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 143,821

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

Read SEC document
March 01, 2021 Filed Mar 4, 2021 01:42 UTC
Gordon David N.Chief Medical Officer
Exercise / conversionRestricted stock units · Derivative 20,600 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-017555 · doc4.xml · derivative · entry 7

Gordon David N. · CIK 0001751167 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,200

Underlying: Common Stock · 20,600 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

F5 · derivative.exercise_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2020, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.

F5 · derivative.expiration_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2020, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.

Read SEC document
March 01, 2021 Filed Mar 4, 2021 01:42 UTC
Gordon David N.Chief Medical Officer
GrantRestricted stock units · Derivative 28,400 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-017555 · doc4.xml · derivative · entry 6

Gordon David N. · CIK 0001751167 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,400

Underlying: Common Stock · 28,400 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

F4 · derivative.exercise_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2022, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.

F4 · derivative.expiration_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2022, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.

Read SEC document
March 01, 2021 Filed Mar 4, 2021 01:42 UTC
Gordon David N.Chief Medical Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 99,500 $0.00 Strike: $24.06 $0.00
Disclosure

SEC source: 0001209191-21-017555 · doc4.xml · derivative · entry 5

Gordon David N. · CIK 0001751167 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,500

Underlying: Common Stock · 99,500 shares

Expires 2031-02-28

F3 · derivative.exercise_date: Exercisable with respect to 25% of the shares subject to the option vesting on each of the first, second, third and fourth anniversaries of the grant date, subject to Reporting Person's continuous service through each such date.

Read SEC document
March 01, 2021 Filed Mar 4, 2021 01:42 UTC
Gordon David N.Chief Medical Officer
Tax withholdingCommon Stock 5,660 $24.06 $136,179.60
Disclosure

SEC source: 0001209191-21-017555 · doc4.xml · nonDerivative · entry 2

Gordon David N. · CIK 0001751167 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,475

F2 · kind: The transaction reported represents the withholding of shares by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of the restricted stock units being reported in this Form 4.

Read SEC document
March 01, 2021 Filed Mar 4, 2021 01:42 UTC
Gordon David N.Chief Medical Officer
Exercise / conversionCommon Stock 20,600 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-017555 · doc4.xml · nonDerivative · entry 1

Gordon David N. · CIK 0001751167 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,135

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

Read SEC document
March 01, 2021 Filed Mar 4, 2021 01:36 UTC
Ruffo FrankChief Financial Officer
Exercise / conversionRestricted stock units · Derivative 25,750 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-017533 · doc4.xml · derivative · entry 7

Ruffo Frank · CIK 0001654450 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,500

Underlying: Common Stock · 25,750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

F5 · derivative.exercise_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2020, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.

F5 · derivative.expiration_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2020, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.

Read SEC document
March 01, 2021 Filed Mar 4, 2021 01:36 UTC
Ruffo FrankChief Financial Officer
GrantRestricted stock units · Derivative 33,200 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-017533 · doc4.xml · derivative · entry 6

Ruffo Frank · CIK 0001654450 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,200

Underlying: Common Stock · 33,200 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

F4 · derivative.exercise_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2022, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.

F4 · derivative.expiration_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2022, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.

Read SEC document
March 01, 2021 Filed Mar 4, 2021 01:36 UTC
Ruffo FrankChief Financial Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 116,000 $0.00 Strike: $24.06 $0.00
Disclosure

SEC source: 0001209191-21-017533 · doc4.xml · derivative · entry 5

Ruffo Frank · CIK 0001654450 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,000

Underlying: Common Stock · 116,000 shares

Expires 2031-02-28

F3 · derivative.exercise_date: Exercisable with respect to 25% of the shares subject to the option vesting on each of the first, second, third and fourth anniversaries of the grant date, subject to Reporting Person's continuous service through each such date.

Read SEC document
March 01, 2021 Filed Mar 4, 2021 01:36 UTC
Ruffo FrankChief Financial Officer
Tax withholdingCommon Stock 7,333 $24.06 $176,431.98
Disclosure

SEC source: 0001209191-21-017533 · doc4.xml · nonDerivative · entry 2

Ruffo Frank · CIK 0001654450 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 233,606

F2 · kind: The transaction reported represents the withholding of shares by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of the restricted stock units being reported in this Form 4.

Read SEC document
March 01, 2021 Filed Mar 4, 2021 01:36 UTC
Ruffo FrankChief Financial Officer
Exercise / conversionCommon Stock 25,750 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-017533 · doc4.xml · nonDerivative · entry 1

Ruffo Frank · CIK 0001654450 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 240,939

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

Read SEC document
March 01, 2021 Filed Mar 4, 2021 01:32 UTC
Walker NealDirector · President and CEO
Exercise / conversionRestricted stock units · Derivative 96,150 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-017519 · doc4.xml · derivative · entry 7

Walker Neal · CIK 0001604457 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 192,300

Underlying: Common Stock · 96,150 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

F5 · derivative.exercise_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2020, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.

F5 · derivative.expiration_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2020, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.

Read SEC document
March 01, 2021 Filed Mar 4, 2021 01:32 UTC
Walker NealDirector · President and CEO
GrantRestricted stock units · Derivative 73,100 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-017519 · doc4.xml · derivative · entry 6

Walker Neal · CIK 0001604457 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,100

Underlying: Common Stock · 73,100 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

F4 · derivative.exercise_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2022, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.

F4 · derivative.expiration_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2022, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.

Read SEC document
March 01, 2021 Filed Mar 4, 2021 01:32 UTC
Walker NealDirector · President and CEO
GrantEmployee Stock Option (Right to Buy) · Derivative 255,800 $0.00 Strike: $24.06 $0.00
Disclosure

SEC source: 0001209191-21-017519 · doc4.xml · derivative · entry 5

Walker Neal · CIK 0001604457 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 255,800

Underlying: Common Stock · 255,800 shares

Expires 2031-02-28

F3 · derivative.exercise_date: Exercisable with respect to 25% of the shares subject to the option vesting on each of the first, second, third and fourth anniversaries of the grant date, subject to Reporting Person's continuous service through each such date.

Read SEC document
March 01, 2021 Filed Mar 4, 2021 01:32 UTC
Walker NealDirector · President and CEO
Tax withholdingCommon Stock 39,792 $24.06 $957,395.52
Disclosure

SEC source: 0001209191-21-017519 · doc4.xml · nonDerivative · entry 2

Walker Neal · CIK 0001604457 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,212,156

F2 · kind: The transaction reported represents the withholding of shares by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of the restricted stock units being reported in this Form 4.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.